is jardiance a glp-1 inhibitor AHA: Lilly, Boehringer's cuts CV hospitalizations over rival diabetes meds Is Jardiance a GLP-1? 2026

Ozempic (semaglutide) is an injectable drug that is FDA-approved for use in people with type 2 diabetes

Ozempic, Wegovy, and Rybelsus are registered trademarks of Novo Nordisk A/S

Mechanistically, even small stimulation of GLP-1 receptors can: Reduce hunger and cravings, making it easier to stick to a reduced-calorie eating pattern Smooth out blood sugar spikes after meals, which may reduce energy crashes and rebound hunger Support improvements in weight-related markers such as HbA1c, especially when combined with lifestyle changes However, it is important to be clear about the evidence

Glucagon agonism is the new ingredient

Medication itself is billed separately at the manufacturer's self-pay tier (currently $349 for Zepbound 2.5mg vials and $499 for higher doses through LillyDirect partnership)

Transporter assays for SGLT1 (Sodium-GLUcose Transporter 1) and GLUT2 (Glucose Transporter 2) are also available